Nautilus Biotechnology, Inc. Annual Depreciation in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Nautilus Biotechnology, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2023.
  • Nautilus Biotechnology, Inc. Depreciation for the quarter ending September 30, 2024 was $500K, unchanged year-over-year.
  • Nautilus Biotechnology, Inc. Depreciation for the twelve months ending September 30, 2024 was $2.08M, a 28.3% increase year-over-year.
  • Nautilus Biotechnology, Inc. annual Depreciation for 2023 was $1.85M, a 51.9% increase from 2022.
  • Nautilus Biotechnology, Inc. annual Depreciation for 2022 was $1.22M, a 19.4% increase from 2021.
  • Nautilus Biotechnology, Inc. annual Depreciation for 2021 was $1.02M, a 43.5% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.85M +$632K +51.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $1.22M +$198K +19.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $1.02M +$309K +43.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-23
2020 $710K Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.